Open access · US-GOV via ClinicalTrials.gov Clinical trial

SAFETY HUMAN IN USE TEST UNDER GYNECOLOGICAL CONTROL FOR THE APPRECIATION OF SKIN ACCEPTABILITY OF THE PRODUCT GINPI REF. GINPI BATCH: 10/06/2024 IN HEALTHY FEMALE ADULT VOLUNTEERS

Authors not listed

i+Med S.Coop. · 2024

Telomere attrition Human Randomized controlled trial

Abstract

The main objective of this study was to confirm skin acceptability of the product GINPI REF. GINPI BATCH: 10/06/2024 applied under normal use conditions in healthy female adult volunteers, under gynecological control, by means of the evaluation of organoleptic characteristics and subjective efficacy of the study product by the volunteers. Other (secondary) objective was the assessment of unexpected adverse events referred by the volunteers as well as possible reactions observed by the investigator.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-23 MST

Cite this

APA

Anonymous. (2024). SAFETY HUMAN IN USE TEST UNDER GYNECOLOGICAL CONTROL FOR THE APPRECIATION OF SKIN ACCEPTABILITY OF THE PRODUCT GINPI REF. GINPI BATCH: 10/06/2024 IN HEALTHY FEMALE ADULT VOLUNTEERS. <em>i+Med S.Coop.</em>. https://clinicaltrials.gov/study/NCT07533474

Vancouver

Anonymous. SAFETY HUMAN IN USE TEST UNDER GYNECOLOGICAL CONTROL FOR THE APPRECIATION OF SKIN ACCEPTABILITY OF THE PRODUCT GINPI REF. GINPI BATCH: 10/06/2024 IN HEALTHY FEMALE ADULT VOLUNTEERS. i+Med S.Coop.. 2024.

BibTeX

@misc{anon2024SAFETY, title = {SAFETY HUMAN IN USE TEST UNDER GYNECOLOGICAL CONTROL FOR THE APPRECIATION OF SKIN ACCEPTABILITY OF THE PRODUCT GINPI REF. GINPI BATCH: 10/06/2024 IN HEALTHY FEMALE ADULT VOLUNTEERS}, author = {Anonymous}, journal = {i+Med S.Coop.}, year = {2024}, }